Plasma neurofilament light chain as a biomarker of Alzheimer’s disease in Subjective Cognitive Decline and Mild Cognitive Impairment

INTRODUCTION: Neurofilament light chain (NfL) is becoming increasingly notable in neurological diseases including AD, and it has been suggested as a new peripherical biomarker of neurodegeneration. We aimed to compare plasma NfL levels among Subjective Cognitive Decline (SCD), Mild Cognitive Impairm...

Descripción completa

Detalles Bibliográficos
Autores principales: Giacomucci, Giulia, Mazzeo, Salvatore, Bagnoli, Silvia, Ingannato, Assunta, Leccese, Deborah, Berti, Valentina, Padiglioni, Sonia, Galdo, Giulia, Ferrari, Camilla, Sorbi, Sandro, Bessi, Valentina, Nacmias, Benedetta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293849/
https://www.ncbi.nlm.nih.gov/pubmed/35288777
http://dx.doi.org/10.1007/s00415-022-11055-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293849/
https://www.ncbi.nlm.nih.gov/pubmed/35288777
http://dx.doi.org/10.1007/s00415-022-11055-5

Ejemplares similares